PIRODOG LYOPHILISAT ET SOLVANT POUR SUSPENSION INJECTABLE POUR CHIENS
PIRODOG LYOPHILISAT ET SOLVANT POUR SUSPENSION INJECTABLE POUR CHIENS
Authorised
- Babesia canis, soluble parasite antigen, Inactivated
Product identification
Medicine name:
PIRODOG LYOPHILISAT ET SOLVANT POUR SUSPENSION INJECTABLE POUR CHIENS
Active substance:
- Babesia canis, soluble parasite antigen, Inactivated
Target species:
-
Dog
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Babesia canis, soluble parasite antigen, Inactivated2.20/log10 (50% cell culture infectious dose)/dose1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AO
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Available in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/9818330 0/1985
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 4/04/2022